Bone Densitometer Systems

Bone Densitometer Systems Market Outlook

As of 2023, the global bone densitometer systems market is valued at approximately $1.2 billion, with a projected compound annual growth rate (CAGR) of around 6.1% from 2025 to 2035. The growing incidence of osteoporosis and other bone-related diseases, coupled with an aging population, is significantly driving market expansion. Furthermore, the increasing awareness of bone health and the necessity for early diagnosis are propelling demand for advanced bone densitometer systems. The enhancement of technology with the incorporation of portable and user-friendly devices is also contributing positively to market growth. In addition, the rise in healthcare expenditure and the establishment of specialized clinics focusing on bone health are expected to fuel the market trend over the forecast period.

Growth Factor of the Market

The bone densitometer systems market is experiencing significant growth due to various factors that enhance its demand globally. One of the primary drivers is the increasing incidence of osteoporosis, which is particularly prevalent among the elderly population. The World Health Organization (WHO) estimates that the number of people over 60 years will surpass two billion by 2050, indicating a growing need for effective bone health monitoring and diagnostic solutions. Additionally, advancements in technology, such as the development of low-cost, portable densitometers, have made these devices more accessible to a broader range of healthcare settings, including outpatient clinics and even home care environments. These advancements allow for more frequent and convenient monitoring of bone density. Furthermore, government initiatives aimed at promoting preventive healthcare and awareness campaigns about bone-related diseases are also contributing significantly to market growth. The increasing popularity of preventive health screenings among consumers is expanding the target demographic for bone densitometer systems.

Key Highlights of the Market

• Rising prevalence of osteoporosis and related bone disorders.
• Technological advancements leading to portable and user-friendly devices.
• Government initiatives promoting preventive healthcare and awareness.
• Increased healthcare expenditure and investment in specialized clinics.
• Growing focus on early diagnosis and treatment options for bone health.

By Product Type

Central DEXA Bone Densitometers:

Central DEXA bone densitometers are the gold standard for measuring bone mineral density (BMD) and are primarily used in hospitals and specialized medical centers. These systems utilize dual-energy X-ray absorptiometry technology, which provides precise measurements of bone density in the lumbar spine and hip regions. The accuracy of central DEXA systems makes them essential for diagnosing osteoporosis and assessing fracture risk in patients. Moreover, the ability to perform body composition analysis adds value to these devices, allowing healthcare professionals to evaluate lean muscle and fat mass. The demand for central DEXA systems is anticipated to increase as healthcare providers focus on improving patient outcomes through early detection and intervention strategies for bone health.

Peripheral Bone Densitometers:

Peripheral bone densitometers are portable devices used for assessing bone density in peripheral sites such as the wrist, heel, and finger. Their compact design and ease of use make them suitable for outpatient settings and primary care facilities. These devices provide quick and non-invasive assessments, allowing for immediate patient feedback. While peripheral bone densitometers may not provide as comprehensive a measurement as central DEXA, their accessibility and affordability make them popular for initial screenings and risk assessments in populations at risk for osteoporosis. The rising preference for point-of-care testing is expected to further drive the adoption of peripheral bone densitometers.

Quantitative Ultrasound Bone Densitometers:

Quantitative ultrasound (QUS) bone densitometers use sound waves to assess bone density, particularly in peripheral sites. They are non-invasive and do not involve radiation exposure, making them a safer option for certain patient populations, such as children and pregnant women. QUS devices are increasingly being utilized in screening programs due to their rapid results and ease of use. Although they may not provide as accurate measurements as DEXA systems, their ability to predict fracture risk adds value in clinical settings. The growing emphasis on minimizing radiation exposure is likely to contribute to the popularity of QUS devices, particularly in primary care and outpatient environments.

Qualitative Ultrasound Bone Densitometers:

Qualitative ultrasound bone densitometers assess bone quality and structure rather than density, providing valuable insights into bone strength and fracture risk. These devices are particularly useful in research settings and among populations where traditional density measurements may not provide a complete picture of bone health. By evaluating the mechanical properties of bone, qualitative ultrasound can help identify patients at higher risk for fractures, thereby informing treatment decisions. The market for qualitative ultrasound devices is expected to grow as the understanding of bone health evolves and healthcare providers seek more comprehensive assessments of bone quality.

Radiographic Absorptiometry Bone Densitometers:

Radiographic absorptiometry bone densitometers utilize standard X-rays to measure bone density, specifically of the hand or wrist. This technique is less commonly used than DEXA but offers a cost-effective alternative in settings where advanced imaging equipment may not be available. The simplicity of the method allows for widespread use in primary care settings, thus facilitating early detection of bone health issues. As healthcare providers continue to seek cost-effective solutions for bone density assessments, radiographic absorptiometry devices may see a resurgence in popularity, particularly in underserved regions and facilities.

By Application

Hospitals:

Hospitals represent a significant segment of the bone densitometer systems market, as they are equipped with advanced technology and specialized personnel to conduct comprehensive bone density assessments. Central DEXA systems are predominantly utilized in hospitals, where accurate and reliable measurements are crucial for diagnosing osteoporosis and determining treatment plans. The high patient volume in hospitals necessitates the availability of advanced diagnostic tools, which drives the demand for bone densitometer systems. Additionally, hospitals often serve as referral centers for patients requiring specialized care, further fueling the market for these systems.

Diagnostic Centers:

Diagnostic centers play a vital role in the bone densitometer systems market by providing specialized testing services for patients referred by healthcare providers. These centers are typically equipped with state-of-the-art imaging technology, allowing for accurate and timely assessments of bone density. The convenience and accessibility of diagnostic centers make them a preferred option for patients seeking bone health evaluations. As the awareness of osteoporosis and the importance of early detection grows, the demand for bone densitometer systems in diagnostic centers is expected to rise, resulting in increased investments in advanced imaging technology.

Specialty Clinics:

Specialty clinics focusing on osteoporosis and bone health offer targeted services for patients at risk of developing bone-related disorders. These clinics are often staffed by healthcare professionals specializing in bone health, providing comprehensive assessments and personalized treatment plans. The use of bone densitometer systems in specialty clinics enhances the ability to monitor patients' bone health over time and adjust treatment protocols accordingly. As the trend toward personalized medicine continues, the role of specialty clinics in the bone densitometer market is likely to expand, driving demand for advanced diagnostic tools.

Research Institutes:

Research institutes are crucial in advancing knowledge about bone health and osteoporosis through clinical studies and trials. These institutions utilize bone densitometer systems to collect data on bone density, quality, and other related parameters for various research purposes. The application of bone densitometry in research helps identify risk factors, improve diagnostic criteria, and evaluate treatment outcomes. As research initiatives focused on osteoporosis and related conditions increase, the demand for bone densitometer systems in research settings is expected to grow, contributing to the overall market expansion.

Others:

This category encompasses various settings where bone densitometer systems may be utilized, including private practices, rehabilitation centers, and home healthcare services. These facilities may use portable or less advanced devices to provide initial screenings and assessments for patients at risk of osteoporosis. The demand in this segment is influenced by the push for preventive healthcare and the increasing emphasis on early diagnosis. With the shift towards value-based care and the need for accessible healthcare solutions, the role of bone densitometer systems in these smaller facilities is likely to expand.

By End User

Women:

The women’s segment is a significant contributor to the bone densitometer systems market due to the higher risk of osteoporosis and related bone disorders in females, particularly after menopause. Hormonal changes resulting from menopause lead to accelerated bone loss, making regular monitoring of bone density essential for early detection and intervention. As awareness of osteoporosis grows among women, healthcare providers are increasingly recommending bone density screenings as a preventive measure. This trend is expected to drive demand for bone densitometer systems specifically designed for female patients.

Men:

While osteoporosis is often associated with women, the condition also significantly affects men, particularly those over 70 years of age or with risk factors such as low testosterone levels or chronic diseases. The increasing recognition of osteoporosis in men is fostering a demand for bone densitometer systems in this demographic. Healthcare providers are becoming more proactive in screening for bone density issues in men, leading to greater adoption of these diagnostic tools. The market for bone densitometers is likely to grow as awareness campaigns target male populations at risk of osteoporosis.

Pediatric:

Pediatric patients represent a unique segment in the bone densitometer systems market, as early identification of bone health issues can significantly impact long-term outcomes. Conditions such as osteogenesis imperfecta and other metabolic bone diseases necessitate specialized monitoring and assessment. Pediatric bone densitometers are designed to accommodate the specific needs of younger patients, ensuring accurate and safe measurements. As the focus on childhood health and preventive care expands, the market for bone densitometers catering to pediatric patients is expected to witness growth.

Geriatric:

The geriatric population is a key end-user of bone densitometer systems due to the increased prevalence of osteoporosis and related fractures in older adults. Age-related bone loss, combined with comorbidities, puts this demographic at a higher risk for bone health issues. Regular screening and monitoring are crucial in this population to reduce fracture risks and improve quality of life. The growing recognition of the need for geriatric care and the integration of bone health assessments into routine healthcare practices are expected to drive demand for bone densitometer systems in this segment.

Others:

This category includes end-users such as athletes, individuals with chronic illnesses, and those taking medications that affect bone density. These populations may require periodic assessments to monitor bone health and prevent complications. The demand for bone densitometer systems in this segment is influenced by the increasing focus on personalized healthcare and the need for tailored monitoring of individuals at risk for bone health issues. As healthcare providers strive to meet the unique needs of diverse populations, the role of bone densitometer systems is likely to expand.

By Technology

Dual Energy X-ray Absorptiometry:

Dual Energy X-ray Absorptiometry (DEXA) is the most widely used technology for measuring bone mineral density and is considered the gold standard in bone health assessments. DEXA utilizes two X-ray beams at different energy levels to differentiate between bone and soft tissue, providing accurate measurements at key skeletal sites such as the hip and spine. The accuracy and reliability of DEXA make it essential for diagnosing osteoporosis and assessing fracture risk. As technology continues to advance, newer DEXA systems are being developed with enhanced features such as improved image quality and faster scanning times, further solidifying their market position.

Quantitative Ultrasound:

Quantitative ultrasound (QUS) is a non-invasive and radiation-free technology used to assess bone density in peripheral sites. QUS devices measure the speed of sound waves traveling through bone, providing information on bone density and quality. While QUS may not offer the same level of precision as DEXA, its portability and ease of use make it a valuable tool for initial screenings and risk assessments. The growing emphasis on patient safety and the minimization of radiation exposure are contributing to the increasing adoption of QUS technology in various healthcare settings.

Radiographic Absorptiometry:

Radiographic absorptiometry utilizes standard X-ray technology to assess bone density, typically in the hands or wrists. This method is less prevalent than DEXA, but it offers a cost-effective alternative for facilities lacking advanced imaging capabilities. Radiographic absorptiometry is easy to perform and provides quick results, making it suitable for primary care settings. While it may not yield the same level of detailed information as DEXA, its accessibility and affordability position it as a valuable option in the market for bone densitometer systems.

Single Energy X-ray Absorptiometry:

Single Energy X-ray Absorptiometry (SXA) is a less common form of bone density measurement that uses a single beam of X-ray energy. While SXA is generally less accurate than DEXA, it can be utilized in specific situations where other technologies are not available. The simplicity and lower cost associated with SXA make it an attractive option for various healthcare settings. Its role in the market may be limited compared to more advanced technologies, but it still provides valuable insights into bone health in certain populations.

Others:

This category encompasses other emerging technologies and methodologies for assessing bone health, such as advanced imaging techniques and novel biomarkers. These technologies are in various stages of research and development, and while they may not yet be widely adopted, they hold potential for future applications in bone densitometry. As the field of bone health evolves, innovations in technology may lead to improved diagnostic capabilities and enhanced patient care, further expanding the market for bone densitometer systems.

By Region

The bone densitometer systems market exhibits significant regional variations influenced by factors such as healthcare infrastructure, population demographics, and economic development. North America holds a prominent position in the global market, accounting for over 40% of the total share. The U.S. is the largest contributor due to the presence of advanced healthcare facilities, a high prevalence of osteoporosis, and increasing awareness regarding bone health. The North American market is expected to grow at a CAGR of 5.6% during the forecast period, driven by technological advancements and rising healthcare expenditure.

In Europe, the market for bone densitometer systems is also robust, with countries such as Germany, France, and the UK leading in terms of adoption. The increasing geriatric population and growing awareness of bone health issues are prompting healthcare providers to invest in advanced diagnostic tools. The European market is projected to experience a CAGR of 6.0% from 2025 to 2035, reflecting the ongoing efforts towards preventive healthcare and early diagnosis. Meanwhile, the Asia Pacific region is emerging as a significant market, fueled by rising healthcare spending, increasing awareness of osteoporosis, and improving healthcare infrastructure. The Asia Pacific market is expected to see growth at a CAGR of 7.2%, driven by the demand for advanced medical technologies and rising incidences of bone-related disorders.

Opportunities

The bone densitometer systems market presents numerous opportunities for growth, particularly through technological advancements that enhance diagnostic capabilities and patient care. The integration of artificial intelligence and machine learning algorithms into bone densitometry devices has the potential to significantly improve the accuracy and efficiency of bone health assessments. Such innovations can facilitate personalized healthcare solutions by analyzing patient data to provide tailored recommendations for osteoporosis management. Additionally, the development of portable bone densitometers that can be used in outpatient settings or even at home is likely to expand access to diagnostic services, particularly in rural or underserved areas. This convenience not only promotes early detection but also encourages individuals to prioritize their bone health, further driving market growth.

Moreover, there exists a substantial opportunity for market expansion in emerging economies. Countries in Asia, Latin America, and the Middle East are experiencing economic growth, leading to increased healthcare investments and infrastructure development. The rising awareness of osteoporosis and associated health risks in these regions is fueling demand for effective diagnostic solutions. As governments and private sector players invest in healthcare initiatives, the market for bone densitometer systems is poised for growth. Collaborations between manufacturers and local healthcare providers can enhance distribution networks and improve accessibility, ultimately contributing to improved health outcomes for diverse populations.

Threats

Despite the promising growth trajectory of the bone densitometer systems market, several threats could impact its expansion. One major concern is the increasing competition among manufacturers, leading to pricing pressures and potential compromises in product quality. As more companies enter the market with similar products, the differentiation of offerings becomes critical. Manufacturers may be compelled to reduce prices to remain competitive, which could negatively affect profit margins. Furthermore, the rapid technological advancements in the medical imaging field may outpace the development and adoption of bone densitometry systems, making it essential for companies to stay ahead of industry trends to maintain their market position.

Another significant threat is the potential for regulatory challenges and compliance issues that may arise in different regions. Each country has its own regulations concerning medical devices, and navigating these can be complex and time-consuming. Compliance with stringent regulations can lead to delays in product launches and increased costs for manufacturers. Additionally, the ongoing pandemic has highlighted the vulnerabilities in global supply chains, which can affect the availability of key components and materials needed for manufacturing bone densitometer systems. In times of crisis, healthcare budgets may also be reallocated, affecting investment in new medical technologies and equipment.

Competitor Outlook

• Hologic, Inc.
• GE Healthcare
• Fujifilm Holdings Corporation
• Philips Healthcare
• Siemens Healthineers
• Scanflex Medical
• Medtronic plc
• Bone Health Technologies LLC
• OsteoSys Co., Ltd.
• Zonare Medical Systems
• Radiology Partners, Inc.
• Hitachi Medical Systems
• Contextual Robotics
• OsteoMed LLC
• ICR Co. Ltd.

The competitive landscape of the bone densitometer systems market is characterized by the presence of several key players striving to innovate and capture market share. Leading companies such as Hologic, Inc. and GE Healthcare dominate the market with their advanced central DEXA systems, which are recognized for their precision and reliability. Hologic, in particular, has invested heavily in research and development to enhance the capabilities of its bone densitometers, including the introduction of advanced imaging technologies and software solutions that improve diagnostic accuracy. These efforts underscore the company's commitment to maintaining its leadership position within the industry.

Other notable players like Siemens Healthineers and Philips Healthcare are also making significant strides in the market by incorporating cutting-edge technology into their bone densitometer systems. Siemens Healthineers is focusing on the integration of artificial intelligence and machine learning into its imaging devices, which has the potential to streamline workflows and enhance patient outcomes. Additionally, Philips Healthcare is exploring partnerships with healthcare organizations to improve accessibility to bone health monitoring, thereby expanding its market reach. The competitive dynamics of the market are continuously evolving, as companies seek to differentiate themselves through product innovation and strategic collaborations.

Smaller companies and startups are also entering the bone densitometer systems market, bringing fresh ideas and technologies to the industry. For instance, companies like OsteoSys Co., Ltd. and Contextual Robotics are developing portable and user-friendly devices designed to cater to the growing demand for accessible bone health assessments. These emerging players are leveraging advancements in technology to create solutions that meet the unique needs of diverse populations, including those in rural or underserved areas. As the market continues to expand, the competitive landscape is likely to become increasingly dynamic, with established companies and new entrants vying for market share.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 ICR Co. Ltd.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 OsteoMed LLC
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 GE Healthcare
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Hologic, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Medtronic plc
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Scanflex Medical
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 OsteoSys Co., Ltd.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Philips Healthcare
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Contextual Robotics
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Siemens Healthineers
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Zonare Medical Systems
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Hitachi Medical Systems
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Radiology Partners, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Bone Health Technologies LLC
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Fujifilm Holdings Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Bone Densitometer Systems Market, By End User
    • 6.1.1 Women
    • 6.1.2 Men
    • 6.1.3 Pediatric
    • 6.1.4 Geriatric
    • 6.1.5 Others
  • 6.2 Bone Densitometer Systems Market, By Technology
    • 6.2.1 Dual Energy X-ray Absorptiometry
    • 6.2.2 Quantitative Ultrasound
    • 6.2.3 Radiographic Absorptiometry
    • 6.2.4 Single Energy X-ray Absorptiometry
    • 6.2.5 Others
  • 6.3 Bone Densitometer Systems Market, By Application
    • 6.3.1 Hospitals
    • 6.3.2 Diagnostic Centers
    • 6.3.3 Specialty Clinics
    • 6.3.4 Research Institutes
    • 6.3.5 Others
  • 6.4 Bone Densitometer Systems Market, By Product Type
    • 6.4.1 Central DEXA Bone Densitometers
    • 6.4.2 Peripheral Bone Densitometers
    • 6.4.3 Quantitative Ultrasound Bone Densitometers
    • 6.4.4 Qualitative Ultrasound Bone Densitometers
    • 6.4.5 Radiographic Absorptiometry Bone Densitometers

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Bone Densitometer Systems Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Bone Densitometer Systems market is categorized based on

By Product Type

• Central DEXA Bone Densitometers
• Peripheral Bone Densitometers
• Quantitative Ultrasound Bone Densitometers
• Qualitative Ultrasound Bone Densitometers
• Radiographic Absorptiometry Bone Densitometers

By Application

• Hospitals
• Diagnostic Centers
• Specialty Clinics
• Research Institutes
• Others

By End User

• Women
• Men
• Pediatric
• Geriatric
• Others

By Technology

• Dual Energy X-ray Absorptiometry
• Quantitative Ultrasound
• Radiographic Absorptiometry
• Single Energy X-ray Absorptiometry
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Hologic, Inc.
• GE Healthcare
• Fujifilm Holdings Corporation
• Philips Healthcare
• Siemens Healthineers
• Scanflex Medical
• Medtronic plc
• Bone Health Technologies LLC
• OsteoSys Co., Ltd.
• Zonare Medical Systems
• Radiology Partners, Inc.
• Hitachi Medical Systems
• Contextual Robotics
• OsteoMed LLC
• ICR Co. Ltd.